| Melodiol Global Health Limited (ME1) ORDINARY FULLY PAID |
Health Care |
- |
Application for quotation of securities - ME1
|
15 Aug 2024 9:14AM |
$0.001 |
$0.001 |
fallen by
0%
|
|
| Noviqtech Limited (NVQ) ORDINARY FULLY PAID |
Information Technology |
$7 |
Proposed issue of securities - NVQ
|
15 Aug 2024 9:14AM |
$0.028 |
$0.026 |
fallen by
7.14%
|
|
| Noviqtech Limited (NVQ) ORDINARY FULLY PAID |
Information Technology |
$7 |
NVQ Placement to Drive Carbon Management Solution Globally
|
15 Aug 2024 9:14AM |
$0.028 |
$0.026 |
fallen by
7.14%
|
|
NVQ - Price-sensitive ASX Announcement
Full Release
Key Points
- NoviqTech Limited (ASX:NVQ) has raised $550,000 through a placement.
- The placement involved issuing 24 million fully paid ordinary shares at $0.025 per share with one free attaching option per share.
- The attaching options are exercisable at $0.08 and expire on 24 June 2026, subject to shareholder approval.
- Peak Asset Management acted as Lead Manager receiving a 6% management and selling fee and 2 million options.
- The placement price represents a 10.71% discount to the last closing price and a 16.67% discount to the 5-day VWAP.
- NoviqTech CEO, Freddy El Turk, highlighted the support for the Carbon Central platform to monitor and report carbon emissions globally.
- Funds will be used to expand the Carbon Central solution targeting aviation, energy, and hydrogen sectors.
- A Share Purchase Plan (SPP) will also raise up to $300,000 for eligible shareholders in Australia and New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Ethical Investment Limited (AEF) ORDINARY FULLY PAID |
Financials |
$665 |
Change in substantial shareholding for RWL
|
15 Aug 2024 9:13AM |
$3.770 |
$5.860 |
risen by
55.44%
|
|
| Rubicon Water Limited (RWL) ORDINARY FULLY PAID |
Information Technology |
$58 |
Change in substantial shareholding from AEF
|
15 Aug 2024 9:13AM |
$0.230 |
$0.240 |
risen by
4.35%
|
|
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
$638 |
Notification of cessation of securities - RUL
|
15 Aug 2024 9:13AM |
$2.530 |
$2.880 |
risen by
13.83%
|
|
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
15 Aug 2024 9:12AM |
$2.950 |
$2.590 |
fallen by
12.20%
|
|
| AKORA Resources Limited (AKO) ORDINARY FULLY PAID |
Materials |
$16 |
Satrokala Iron Ore Project First ExploratoryDrilling Revised
|
15 Aug 2024 9:11AM |
$0.098 |
$0.120 |
risen by
22.45%
|
|
AKO - Price-sensitive ASX Announcement
Full Release
Key Points
- First five drill holes at the Satrokala Project completed.
- Mineralisation within intercepted magnetic anomaly sections being prepared for assays.
- Initial drilling program aimed at testing magnetic anomalies along a 10km strike length.
- Potential mineralisation intercepted in all five drill holes.
- Remaining five planned drill holes to be completed after further geological assessment.
- Satrokala drilling follows positive surface rock sampling and ground magnetic survey results.
- Preliminary findings suggest potential fine and coarse disseminated mineralisation to depths of 100m.
- Magnetic susceptibility readings lower than nearby Bekisopa project.
- Future steps include full assay analysis, mineralogy tests, and further drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Killi Resources Limited (KLI) ORDINARY FULLY PAID |
Materials |
$4 |
Trading Halt
|
15 Aug 2024 9:11AM |
$0.115 |
$0.032 |
fallen by
72.17%
|
|
KLI - Price-sensitive ASX Announcement
Full Release
Key Points
- The trading halt for Killi Resources Limited (ASX: KLI) was requested pending an announcement related to a potential capital raising.
- The trading halt was requested to stay in place until the earlier of the commencement of trading on 19 August 2024 or the release of the announcement.
- The trading halt request was authorized by the Board of Killi Resources Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
$638 |
Update - Notification of buy-back - RUL
|
15 Aug 2024 9:10AM |
$2.530 |
$2.880 |
risen by
13.83%
|
|
| Apollo Minerals Limited (AON) ORDINARY FULLY PAID |
Materials |
$10 |
Drilling Commences at Salanie Gold Project
|
15 Aug 2024 9:08AM |
$0.020 |
$0.011 |
fallen by
45%
|
|
AON - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling program commenced at Salanie Gold Project in Gabon.
- Focus on A1, A3, and P6 high-priority prospects.
- Historical mining from the 1950s demonstrated high-grade gold.
- Visible gold in quartz veining with assays 429g/t Au and 125g/t Au.
- Targets approximately 1,200 meters of diamond drilling.
- Soil sampling results are pending.
- First modern exploration in 70 years.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$37 |
Section 708A Cleansing Notice
|
15 Aug 2024 9:08AM |
$0.016 |
$0.018 |
risen by
12.50%
|
|
| Lykos Metals Limited (LYK) ORDINARY FULLY PAID |
Materials |
$3 |
Investor Presentation
|
15 Aug 2024 9:07AM |
$0.026 |
$0.014 |
fallen by
46.15%
|
|
| Kincora Copper Limited (KCC) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$9 |
Kincora participation in the Sharewise Webinar
|
15 Aug 2024 9:04AM |
$0.048 |
$0.032 |
fallen by
33.33%
|
|
| Connexion Mobility Ltd (CXZ) ORDINARY FULLY PAID |
Information Technology |
$22 |
Update - Notification of buy-back - CXZ
|
15 Aug 2024 9:02AM |
$0.028 |
$0.027 |
fallen by
1.82%
|
|
| AuMEGA Metals Ltd (AAM) ORDINARY FULLY PAID |
Materials |
$21 |
TSXV Management Discussion and Analysis - 30 June 2024
|
15 Aug 2024 9:01AM |
$0.045 |
$0.035 |
fallen by
22.22%
|
|
| CleanSpace Holdings Limited (CSX) ORDINARY FULLY PAID |
Health Care |
$33 |
CEO Update
|
15 Aug 2024 9:01AM |
$0.470 |
$0.420 |
fallen by
10.64%
|
|
CSX - Price-sensitive ASX Announcement
Full Release
Key Points
- CEO Graham McLean will transition to a Non-Executive Director role in late 2024
- Graham McLean joined as Non-Executive Director in February 2022 and became CEO in January 2023
- Mr. McLean focused on resetting strategic growth priorities, reducing costs, and stabilizing financial performance
- CleanSpace reported a 30% increase in sales for FY24
- The company will announce full year results on 27 August 2024
- A search for a new CEO is underway and expected to be completed by late 2024
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Green Critical Minerals Limited (GCM) ORDINARY FULLY PAID |
Materials |
$25 |
Notification of cessation of securities - GCM
|
15 Aug 2024 8:59AM |
$0.002 |
$0.013 |
risen by
525%
|
|
| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$37 |
Notification regarding unquoted securities - SRZ
|
15 Aug 2024 8:59AM |
$0.016 |
$0.018 |
risen by
12.50%
|
|
| American West Metals Limited (AW1) ORDINARY FULLY PAID |
Materials |
$30 |
Assays Confirm Further High-Grade Copper at Storm
|
15 Aug 2024 8:58AM |
$0.140 |
$0.050 |
fallen by
64.29%
|
|
AW1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Assays confirm further near-surface, high-grade copper at the Storm Project, Canada.
- Potential resource upgrade and extension on-track with multiple high-grade copper intervals confirmed by assays at the Cyclone and Chinook Deposits.
- Drilling continues 24/7 with 100 Reverse Circulation drill holes, 13 diamond drill holes, and over 15,500m now completed at Storm.
- Drill hole SR24-11 intersected 19.8m @ 1.2% Cu, 3.0g/t Ag from 12.2m downhole, including 4.6m @ 3.0% Cu, 7.0 g/t Ag.
- Drill hole SR24-21 intersected 13.7m @ 2.1% Cu, 7.9g/t Ag from 67.1m downhole.
- Drill hole SR24-09, located outside of the current resource, intersected 15.2m @ 1.4% Cu, 2.4g/t Ag from 103.6m downhole.
- The Cyclone Deposit assays suggest significant resource expansion potential to the south-west of the deposit.
- The Chinook Deposit assays confirm continuity and extensions of high-grade copper mineralisation.
- The 2024 drill program is progressing rapidly, with exploration activities expanding into the Tempest Prospect.
- The discovery of copper mineralisation at depth has significant implications for the potential copper endowment of the project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AuMEGA Metals Ltd (AAM) ORDINARY FULLY PAID |
Materials |
$21 |
TSXV Interim Financial Statements - 30 June 2024
|
15 Aug 2024 8:58AM |
$0.045 |
$0.035 |
fallen by
22.22%
|
|
| Lachlan Star Limited (LSA) ORDINARY FULLY PAID |
Materials |
$18 |
Investor Presentation - August 2024
|
15 Aug 2024 8:58AM |
$0.070 |
$0.070 |
fallen by
0%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$700 |
PYC to Start Human Trials in Second Blinding Eye Disease
|
15 Aug 2024 8:57AM |
$0.105 |
$1.200 |
risen by
1,042.86%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics has received Human Research Ethics Committee approval to commence clinical trials for its drug candidate in Autosomal Dominant Optic Atrophy (ADOA).
- The company has lodged a Clinical Trial Notification with the Therapeutic Goods Administration and plans to start human studies of the drug candidate in Australia.
- The ADOA program enters human trials after demonstrating the safety and initial efficacy of its RNA conjugate modality in a human eye for the first time in the lead Retinitis Pigmentosa type 11 drug program.
- PYC’s ADOA drug candidate targets approximately 1 in every 35,000 people suffering from this irreversible blinding eye disease, with no current treatment options.
- PYC aims to establish initial human safety and efficacy data for this drug candidate by 2025 before starting a registrational study in 2026.
- PYC-001, the company's drug candidate for ADOA, has been granted Orphan Drug Designation by the US Food and Drug Administration and will undergo a Single Ascending Dose (SAD) study.
- The primary endpoint of the study will be Treatment Emergent Adverse Events (TE-AEs) and Treatment Emergent Serious Adverse Events (TE-SAEs).
- The study will also monitor changes in visual function and functional vision throughout the trial.
- PYC-001 aims to restore the expression of the OPA1 gene to normal functional levels in the retina using PYC’s proprietary drug delivery technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$221 |
Proposed issue of securities - EGH
|
15 Aug 2024 8:56AM |
$0.533 |
$0.520 |
fallen by
2.35%
|
|
| Bluglass Limited (BLG) ORDINARY FULLY PAID |
Information Technology |
$22 |
BluGlass launches Semiconductor Australia conference
|
15 Aug 2024 8:56AM |
$0.030 |
$0.011 |
fallen by
63.33%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
